OncoMed Pharmaceuticals, Inc. Revenue 2013-2018 | OMED

OncoMed Pharmaceuticals, Inc. revenue from 2013 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
OncoMed Pharmaceuticals, Inc. Annual Revenue
(Millions of US $)
2018 $44
2017 $38
2016 $25
2015 $26
2014 $40
2013 $38
2012 $25
2011 $31
2010 $18
OncoMed Pharmaceuticals, Inc. Quarterly Revenue
(Millions of US $)
2018-12-31 $10
2018-09-30 $20
2018-06-30 $7
2018-03-31 $8
2017-12-31 $21
2017-09-30 $5
2017-06-30 $6
2017-03-31 $6
2016-12-31 $6
2016-09-30 $6
2016-06-30 $7
2016-03-31 $6
2015-12-31 $7
2015-09-30 $5
2015-06-30 $5
2015-03-31 $10
2014-12-31 $9
2014-09-30 $19
2014-06-30 $6
2014-03-31 $6
2013-12-31 $19
2013-09-30 $13
2013-06-30 $3
2013-03-31 $3
2012-09-30 $8
2012-06-30 $7